SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-16-007505
Filing Date
2016-02-18
Accepted
2016-02-18 16:42:08
Documents
1
Period of Report
2015-12-30

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 1557
  Complete submission text file 0001493152-16-007505.txt   3239
Mailing Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809
Business Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809 225-227-2384
OncBioMune Pharmaceuticals, Inc (Issuer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 7310 Services-Advertising
Office of Trade & Services

Mailing Address C/O ONCBIOMUNE PHARMACEUTICALS INC., 11441 INDUSTRIPLEX BLVD, SUITE 190 BATON ROUGE LA 70809
Business Address
Hoverman Daniel S. (Reporting) CIK: 0001665931 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-52218 | Film No.: 161438561